Language

News topic

Start: Ende April 2026

All current shortage notices related to Start: Ende April 2026, structured by product, country, active ingredient and reporting period.

4 notices

← All shortages

Denmark

Zyprexa 10 mg pulver til injektionsvæske, opløsning (Orifarm)

Active ingredient: nicht angegeben

View notice details →
Denmark

Dalacin 10 mg/ml kutanemulsion (Pfizer)

Active ingredient: nicht angegeben

View notice details →
Denmark

Rivastigmin "Viatris" 1,5 mg kapsler, hårde

Active ingredient: Rivastigmin (Rivastigminhydrogentartrat)

View notice details →
Denmark

Combigan 2+5 mg/ml øjendråber, opløsning (2care4 ApS)

Active ingredient: nicht angegeben

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.